Lamictal®

DRUG5 trials

Sponsors

Teva Pharmaceuticals USA, University of Malaya, Dr. Reddy's Laboratories Limited

Conditions

HealthyTrigeminal Neuralgia

Phase 1

Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditions

CompletedNCT00835263

Teva Pharmaceuticals USAHealthy

Start: 2002-01-31End: 2002-02-28Updated: 2024-08-19

Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions

CompletedNCT00834561

Teva Pharmaceuticals USAHealthy

Start: 2002-01-31End: 2002-02-28Updated: 2024-08-19

Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition

CompletedNCT01513681

Dr. Reddy's Laboratories LimitedHealthy

Start: 2002-11-30End: 2002-11-30Updated: 2012-01-20

Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition

CompletedNCT01513720

Dr. Reddy's Laboratories LimitedHealthy

Start: 2002-12-31End: 2002-12-31Updated: 2012-01-20

Phase 2

Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia

CompletedNCT00913107

University of MalayaTrigeminal Neuralgia

Start: 2007-09-30End: 2008-06-30Updated: 2010-06-29